NO152089C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater

Info

Publication number
NO152089C
NO152089C NO790165A NO790165A NO152089C NO 152089 C NO152089 C NO 152089C NO 790165 A NO790165 A NO 790165A NO 790165 A NO790165 A NO 790165A NO 152089 C NO152089 C NO 152089C
Authority
NO
Norway
Prior art keywords
pyridon
preparation
carboxylic acid
acid derivatives
therapeutic active
Prior art date
Application number
NO790165A
Other languages
English (en)
Norwegian (no)
Other versions
NO152089B (no
NO790165L (no
Inventor
Alexander Eduard Wick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH51278A external-priority patent/CH639073A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO790165L publication Critical patent/NO790165L/no
Publication of NO152089B publication Critical patent/NO152089B/no
Publication of NO152089C publication Critical patent/NO152089C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO790165A 1978-01-18 1979-01-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater NO152089C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH51278A CH639073A5 (en) 1978-01-18 1978-01-18 4-Pyridone-3-carboxylic acid derivatives and their preparation
CH1173478 1978-11-15

Publications (3)

Publication Number Publication Date
NO790165L NO790165L (no) 1979-07-19
NO152089B NO152089B (no) 1985-04-22
NO152089C true NO152089C (no) 1985-08-14

Family

ID=25684790

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790165A NO152089C (no) 1978-01-18 1979-01-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater

Country Status (25)

Country Link
US (2) US4521535A (fr)
EP (1) EP0003144B1 (fr)
JP (1) JPS54100382A (fr)
KR (1) KR820002111B1 (fr)
AR (1) AR223663A1 (fr)
AT (1) AT369731B (fr)
AU (1) AU521148B2 (fr)
CA (1) CA1110234A (fr)
DE (1) DE2901868A1 (fr)
DK (1) DK20279A (fr)
ES (1) ES476917A1 (fr)
FI (1) FI790103A (fr)
FR (1) FR2415103A1 (fr)
GB (1) GB2013190B (fr)
GR (1) GR73088B (fr)
HU (1) HU179487B (fr)
IE (1) IE47784B1 (fr)
IL (1) IL56421A (fr)
LU (1) LU80794A1 (fr)
MC (1) MC1239A1 (fr)
NL (1) NL7900264A (fr)
NO (1) NO152089C (fr)
NZ (1) NZ189379A (fr)
PT (1) PT69093A (fr)
SE (1) SE7900318L (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1125762A (fr) * 1979-07-13 1982-06-15 Alexander E. Wick Derives d'acide dihydronicotinique et methode de preparation
US4964896A (en) * 1980-05-12 1990-10-23 Monsanto Company Certain-2,6-diphenyl-1,4-dihydro-4-oxo-nicotinates which are useful for inducing male sterility in cereal grain plants
US4936904A (en) * 1980-05-12 1990-06-26 Carlson Glenn R Aryl-4-oxonicotinates useful for inducing male sterility in cereal grain plants
AU539399B2 (en) * 1980-05-12 1984-09-27 Zeneca Limited Substituted oxonicotinates
US4714492A (en) * 1980-05-12 1987-12-22 Rohm And Haas Company Certain 2-phenyl-4-oxo-nicotinates and their use for inducing male sterility in a cereal grain plant
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5980665A (ja) * 1982-10-29 1984-05-10 Toyama Chem Co Ltd 4−オキソ−1,4−ジヒドロニコチン酸誘導体
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben
GB8502424D0 (en) * 1985-01-31 1985-03-06 Pharis R P Promotion of flowering fruit trees
GB9317314D0 (en) * 1993-08-20 1993-10-06 Smithkline Beecham Corp Compounds
EP2149547A1 (fr) * 2008-07-30 2010-02-03 LEK Pharmaceuticals D.D. Procédé pour la synthèse d'ézétimibe et intermédiaires utiles pour celui-ci
WO2015099107A1 (fr) 2013-12-26 2015-07-02 塩野義製薬株式会社 Dérivé cyclique à six chaînons contenant de l'azote et composition pharmaceutique le contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907808A (en) * 1971-05-17 1975-09-23 Sterling Drug Inc 1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
IN142614B (fr) * 1974-08-28 1977-08-06 Lilly Co Eli
CA1125762A (fr) * 1979-07-13 1982-06-15 Alexander E. Wick Derives d'acide dihydronicotinique et methode de preparation
DE3338846A1 (de) * 1982-10-29 1984-05-03 Toyama Chemical Co. Ltd., Tokyo Neue 4-oxo-1,4-dihydronicotinsaeurederivate und salze derselben, verfahren zu ihrer herstellung und antibakterielle mittel mit einem gehalt derselben

Also Published As

Publication number Publication date
GB2013190B (en) 1982-07-14
US4549022A (en) 1985-10-22
DE2901868A1 (de) 1979-07-19
IE47784B1 (en) 1984-06-13
AR223663A1 (es) 1981-09-15
MC1239A1 (fr) 1979-10-26
IE790113L (en) 1979-07-18
US4521535A (en) 1985-06-04
NL7900264A (nl) 1979-07-20
AT369731B (de) 1983-01-25
JPS54100382A (en) 1979-08-08
FR2415103B1 (fr) 1982-11-05
FR2415103A1 (fr) 1979-08-17
ES476917A1 (es) 1979-11-16
HU179487B (en) 1982-10-28
FI790103A (fi) 1979-07-19
NZ189379A (en) 1984-07-06
IL56421A (en) 1982-08-31
IL56421A0 (en) 1979-03-12
NO152089B (no) 1985-04-22
CA1110234A (fr) 1981-10-06
EP0003144A2 (fr) 1979-07-25
PT69093A (en) 1979-02-01
AU4329679A (en) 1979-07-26
SE7900318L (sv) 1979-07-19
EP0003144A3 (en) 1979-08-08
AU521148B2 (en) 1982-03-18
DK20279A (da) 1979-07-19
ATA35079A (de) 1982-06-15
LU80794A1 (de) 1980-02-14
EP0003144B1 (fr) 1981-08-05
GB2013190A (en) 1979-08-08
KR820002111B1 (ko) 1982-11-10
NO790165L (no) 1979-07-19
GR73088B (fr) 1984-02-01

Similar Documents

Publication Publication Date Title
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO802087L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer